Miyakawa Yoshitaka
Department of General Internal Medicine, Center for Thrombosis and Hemostasis, Saitama Medical University Hospital.
Rinsho Ketsueki. 2017;58(5):530-536. doi: 10.11406/rinketsu.58.530.
Both TTP and aHUS are officially designated as intractable diseases by a new Japanese law in 2015. New clinical practice guidelines for TTP and aHUS have been published. Both conditions share some common pathophysiology such as thrombotic microangiopathy. Unfortunately, most professionals in the fields of hematology/oncology are unaware of these diseases. Therefore, I will provide an updated overview of TTP and aHUS in this article.
2015年,日本一项新法律将血栓性血小板减少性紫癜(TTP)和非典型溶血尿毒综合征(aHUS)都正式指定为难治性疾病。关于TTP和aHUS的新临床实践指南已经发布。这两种病症具有一些共同的病理生理学特征,比如血栓性微血管病。遗憾的是,血液学/肿瘤学领域的大多数专业人员并不了解这些疾病。因此,我将在本文中提供TTP和aHUS的最新概述。